Another study demonstrated a similar trend in chronic granulomatous disease (CGD), in which disease progression was promoted by NOX2-producing mo-macs lacking the MHCII+CD206+CD36+ mature phenotype. Here, CYBB is linked to chronic granulomatous disease.